These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35714448)

  • 1. Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein.
    D'Anzi A; Perciballi E; Ruotolo G; Ferrari D; Notaro A; Lombardi I; Gelati M; Frezza K; Bernardini L; Torrente I; De Luca A; La Bella V; Luigi Vescovi A; Rosati J
    Stem Cell Res; 2022 Aug; 63():102835. PubMed ID: 35714448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (UCSCi002-A) from a patient with a variant in TARDBP gene associated with familial amyotrophic lateral sclerosis and frontotemporal dementia.
    Martello F; Lattante S; Doronzio PN; Conte A; Bisogni G; Orteschi D; Luigetti M; Marrucci MA; Zollino M; Sabatelli M; Marangi G
    Stem Cell Res; 2022 Jul; 62():102825. PubMed ID: 35667216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein.
    D'Anzi A; Altieri F; Perciballi E; Ferrari D; Torres B; Bernardini L; Lattante S; Sabatelli M; Vescovi AL; Rosati J
    Stem Cell Res; 2021 May; 53():102356. PubMed ID: 34087986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
    Del Bo R; Ghezzi S; Corti S; Pandolfo M; Ranieri M; Santoro D; Ghione I; Prelle A; Orsetti V; Mancuso M; Sorarù G; Briani C; Angelini C; Siciliano G; Bresolin N; Comi GP
    Eur J Neurol; 2009 Jun; 16(6):727-32. PubMed ID: 19236453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of Plasma microRNA Expression in a
    Ruffo P; Catalano S; La Bella V; Conforti FL
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution.
    De Marco G; Lomartire A; Calvo A; Risso A; De Luca E; Mostert M; Mandrioli J; Caponnetto C; Borghero G; Manera U; Canosa A; Moglia C; Restagno G; Fini N; Tarella C; Giordana MT; Rinaudo MT; Chiò A
    Neuropathol Appl Neurobiol; 2017 Feb; 43(2):133-153. PubMed ID: 27178390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review.
    Lombardi M; Corrado L; Piola B; Comi C; Cantello R; D'Alfonso S; Mazzini L; De Marchi F
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced PHOX2B stability causes axonal growth impairment in motor neurons with TARDBP mutations.
    Mitsuzawa S; Suzuki N; Akiyama T; Ishikawa M; Sone T; Kawada J; Funayama R; Shirota M; Mitsuhashi H; Morimoto S; Ikeda K; Shijo T; Ohno A; Nakamura N; Ono H; Ono R; Osana S; Nakagawa T; Nishiyama A; Izumi R; Kaneda S; Ikeuchi Y; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    Stem Cell Reports; 2021 Jun; 16(6):1527-1541. PubMed ID: 34048688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons.
    Ratti A; Gumina V; Lenzi P; Bossolasco P; Fulceri F; Volpe C; Bardelli D; Pregnolato F; Maraschi A; Fornai F; Silani V; Colombrita C
    Neurobiol Dis; 2020 Nov; 145():105051. PubMed ID: 32827688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene.
    Akter M; Cui H; Abir Hosain M; Ding B
    Stem Cell Res; 2023 Jun; 69():103078. PubMed ID: 36965406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale screening of TARDBP mutation in amyotrophic lateral sclerosis in Japanese.
    Iida A; Kamei T; Sano M; Oshima S; Tokuda T; Nakamura Y; Ikegawa S
    Neurobiol Aging; 2012 Apr; 33(4):786-90. PubMed ID: 20675015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD.
    Imaizumi K; Ideno H; Sato T; Morimoto S; Okano H
    eNeuro; 2022; 9(3):. PubMed ID: 35641224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis.
    Daoud H; Valdmanis PN; Kabashi E; Dion P; Dupré N; Camu W; Meininger V; Rouleau GA
    J Med Genet; 2009 Feb; 46(2):112-4. PubMed ID: 18931000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypes in Swiss patients with familial ALS carrying TARDBP mutations.
    Czell D; Andersen PM; Morita M; Neuwirth C; Perren F; Weber M
    Neurodegener Dis; 2013; 12(3):150-5. PubMed ID: 23327806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation.
    Tracey TJ; Jiang L; Gill MK; Ranie SN; Ovchinnikov DA; Wolvetang EJ; Ngo ST
    Stem Cell Res; 2023 Aug; 70():103137. PubMed ID: 37315423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation.
    Sugai A; Kato T; Koyama A; Koike Y; Konno T; Ishihara T; Onodera O
    Neurobiol Dis; 2019 Oct; 130():104534. PubMed ID: 31310801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis.
    Solski JA; Yang S; Nicholson GA; Luquin N; Williams KL; Fernando R; Pamphlett R; Blair IP
    Amyotroph Lateral Scler; 2012 Sep; 13(5):465-70. PubMed ID: 22424122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
    Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
    Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.